The effect of Zn(II) and streptozotocin administration in the mouse brain

Brain Research

Volumn 1109, Issue 1, 2006, Pages 207-218

  Beltramini, Mariano ^a   Zambenedetti, Pamela ^b   Raso, Michelangelo ^a   IbnlKayat, Meryem Idrissi ^c   Zatta, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b GENERAL HOSPITAL   (Italy)

^c Faculté de Sciences D M Fès   (Italy)

Author keywords

Astrocyte; Metallothionein; Oxidative stress; Streptozotocin; Zinc

Indexed keywords

METAL ION; METALLOTHIONEIN; STREPTOZOCIN; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN FUNCTION; BRAIN TISSUE; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; GLIA CELL; HIPPOCAMPUS; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; METAL METABOLISM; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CHLORIDES; CHROMOGRANIN A; CHROMOGRANINS; DRUG INTERACTIONS; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; IMMUNOHISTOCHEMISTRY; MALE; METALLOPROTEINS; MICE; MICE, INBRED STRAINS; SPECTROPHOTOMETRY; STREPTOZOCIN; TISSUE DISTRIBUTION; TRACE ELEMENTS; ZINC COMPOUNDS;

ANIMALIA; STREPTOMYCES ACHROMOGENES;

EID: 33747787028     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.06.108     Document Type: Article

References (51)

1. Antel J., and Arnold D. Multiple sclerosis. In: Kettenmann, and Ranson B.R. (Eds). Neuroglia (2005), Oxford Univ. Press, Oxford, U.K 489-500
2. Baydas G., Reiter R.J., Yasar A., Tuzcu M., Akdemir I., and Nedzvetskii V.S. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic. Biol. Med. 35 (2003) 797-804
3. Baydas G., Nedzvetskii V.S., Tuzcu M., Yasar A., and Kirichenko S.V. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur. J. Pharmacol. 462 (2003) 67-71
4. Behl C. Oestrogen as a neuroprotective hormone. Nat. Rev., Neurosci. 3 (2003) 433-442
5. Behl C. Estrogen can protect neurons: modes of action. J. Steroid Biochem. Mol. Biol. 83 (2003) 195-197
6. Beltramini M., Zambenedetti P., Wittkowski W., and Zatta P. Effects of steroid hormones on the Zn, Cu and MTI/II levels in mouse brain. Brain Res. 1013 (2004) 134-141
7. Beltramini M., Di Pisa C., Zambenedetti P., Wittkowski W., Mocchegiani E., Musicco M., and Zatta P. Zn and Cu alteration in connection with astrocyte metallothionein I/II overexpression in the mouse brain upon physical stress. Glia 47 (2004) 30-34
8. Bidasee K.R., Nallani K., Yu Y., Cocklin R.R., Zhang Y., Wang M., Dincer U.D., and Besch H.R. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 52 (2003) 1825-1836
9. Binz P.A., and Kägi J.H.R. Metallothionein: molecular evolution and classification. In: Klaassen C.D. (Ed). Metallothioneins IV (1997), Birkhauser Verlag, Basel
10. Chen H., Carlson E.C., Pellet L., Moritz J.T., and Epstein P.N. Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes 50 (2001) 2040-2046
11. Coleman E., Judd R., Hoe L., Dennis J., and Posner P. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48 (2004) 166-1678
12. Coyle P., Philcox J.C., Carey L.C., and Rofe A.M. Metallothionein: the multipurpose protein. Cell. Mol. Life Sci. 59 (2002) 627-647
13. Dirnagl U., and Priller J. Focal cerebral ischemia: the multifaceted role of glial cells. In: Kettermann H., and Ramson B.R. (Eds). Neuroglia, II (2005) 511-520
14. Eidi M., Eidi A., and Zamanizadeh H. Effects of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. J. Ethnopharmacol. 100 (2005) 310-313
15. Espejio C., Carrasco J., Hidalgo J., Penkowa M., Garcia A., Saez-Torres I., and Martinez-Caceres E.M. Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis. Neuroscience 105 (2001) 1055-1065
16. Fergunson S.C., Blane A., Perros P., McCrimmon R.J., Best J.J.K., Wardlaw J., Deary I.J., and Frier B.M. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycaemia. Diabetes 52 (2003) 149-156
17. Fox P.L. The copper-iron chronicle: the story of an intimate relationship. Biometals 16 (2003) 9-40
18. Garcia-Segura L.M., Azcoitia I., and Don Carlos L.L. Neuroprotection by oestradiol. Prog. Neurobiol. 63 (2001) 29-60
19. Gille L., Schott-Ohly P., Friesen N., Schulte in Walde S., Udilova N., Nowl H., and Gleichmann H. Generation of hydroxyl radicals mediated by streptozotocin in pancreatic islets of mice in vitro. Pharmacol. Toxicol. 90 (2002) 317-326
20. Grunnet M. Cerebrovascular disease: diabetes and cerebral atherosclerosis. Neurology 13 (1963) 486-491
21. Hidalgo J., Aschner M., Zatta P., and Vašák M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res. Bull. 55 (2001) 133-145
22. Hidalgo J., Penkowa M., Giralt M., Carrasco J., and Molinero A. Metallothionein expression and oxidative stress in the brain. Methods Enzymol. 348 (2002) 238-249
23. Huang H., Cuajungco M.P., Atwood C.S., Moir R.D., Tanzi R.E., and Bush A.I. Alzheimer's disease, beta-amyloid protein and zinc. J. Nutr. 130 5S Suppl (2000) 1488S-1492S
24. Li X., Chen H., and Epstein P.N. Metalloprotein protects islets from hypoxia and extends islet graft survival by scavenging most kind of reactive oxygen species. J. Biol. Chem. 279 (2004) 765-771
25. Li X., Zhou Z.G., Huang G., Yan X., Yang L., Chen X.Y., and Wang J.P. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes. Ann. N.Y. Acad. Sci. 1037 (2004) 122-126
26. Marks K., Carvou N.J., Debman E.S., Srai S.K., and Unwin R.J. Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane. J. Physiol. 553 (2003) 137-145
27. Milnerowicz H., Chmarek M., Rabczynski J., Milnerowicz S., Nabzdyk S., and Knast W. Immunohistochemical localization of metallothionein in chronic pancreatitis. Pancreas 29 (2004) 28-32
28. Mocchegiani E., Giacconi E.R., Cipriano C., Muzzioli M., Fattoretti P., Bertoni-Freddari C., Isani G., Zambenedetti P., and Zatta P. Zinc-bound metallothioneins as potential biological markers of aging. Brain Res. Bull. 55 (2001) 147-154
29. Moosmann B., and Behl C. Secretory peptide hormones are biochemical antioxidants: structure-activity relationship. Mol. Pharmacol. 61 (2002) 260-268
30. Muranyi M., Masayuki F., He Q., Han A., Yong G., Csiszar K., and Li P.A. Diabetes activates cell death pathway after transient focal cerebral ischemia. Diabetes 52 (2003) 481-486
31. Murata M., Takahashi S., Saito I., and Kawanishi S. Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem. Pharmacol. 57 (1999) 881-888
32. Ohly P., Dhole C., Abel J., Seissler J., and Gleichman H. Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 43 (2000) 1020-1030
33. Parihar M.S., and Hemnani T. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J. Biosci. 28 (2003) 121-128
34. Penkowa M., and Hidalgo J. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-a and apoptotic cell death durino experimental autoimmune encephalomyelitis (EAE). Exp. Neurol. 170 (2001) 1-4
35. Penkowa M., Giralt M., Carrasco J., Hadberg H., and Hidalgo J. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia 32 (2000) 271-285
36. Penkowa M., Flort S., Giralt M., Quintana A., Molinero A., Carrasco J., and Hidalgo J. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizure. J. Neurosci. Res. 15 (2005) 522-534
37. Quilliot D., Walter E., Bonte J.-P., Fruchart J.-C., Duriez P., and Ziegler O. Diabetes mellitus worsen antioxidant status in patients with chronic pancreatitis. Am. J. Clin. Nutr. 81 (2005) 1111-1117
38. Radtke F., Heuchel R., Georgiev O., Hergersberg M., Gariglio M., Dembic Z., and Schaffner W. Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J. 12 (1993) 1355-1362
39. Revsin J., Saravia F., Roig P., Lima A., de Kloet E.R., Homo-Delarche F., and De Nicola A.F. Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes. Brain Res. 1038 (2005) 22-31
40. Saravia F., Revsin Y., Gonzales Deniselle M.C., Gonzales S.L., Roig P., Lima A., Homo-Delarche F., and De Nicola A.F. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res. 957 (2002) 345-353
41. Saravia F., Revsin Y., Lux-Lantos V., Beauquis J., Homo-Delarche F., and De Nicola A.F. Oestradiol restores cell proliferation in dentate gyrus and subventricular zone of streptozotocin-diabetic mice. J. Neuroendocrinol. 16 (2004) 704-710
42. Scheede-Bergdahl C., Penkowa M., Hidalgo J., Olsen D.B., Schjerling P., Prats C., Boushel R., and Dela F. Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes 54 (2005) 3089-3094
43. Scheuhammer A.M., and Cherian M.G. Quantification of metallothionein by silver saturation. Methods Enzymol. 205 (1991) 78-83
44. Strausak D., Mercer J.F., Dieter H.H., Stremmel W., and Multhaup G. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res. Bull. 55 (2001) 175-185
45. Taylor C.G. Zinc, the pancreas, and diabetes: insights from rodent studies and future directions. BioMetals 18 (2005) 305-312
46. Tudor R., Zalewski P.D., and Ratnaike R.N. Zinc in health and chronic disease. J. Nutr. Health Aging 9 (2005) 45-51
47. Ye G., Metreveli N.S., Ren J., and Epstein P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52 (2003) 777-783
48. Zambenedetti P., Giordano R., and Zatta P. Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease. J. Chem. Neuroanat. 15 (1998) 21-26
49. Zambenedetti P., Schmitt H.P., and Zatta P. Metallothionein I-II immunocytochemical reactivity in Binswanger's encephalopathy. J. Alzheimer's Dis. 4 (2002) 459-466
50. In: Zatta P. (Ed). Metal Ions and Neurodegenerative Disorders (2003), World Sci., Singapore
51. Zatta P., Lucchini R., van Rensburg S., and Taylor A. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res. Bull. 62 (2003) 15-28